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INTRODUCTION
Pain during labour and delivery is intense, although there is considerable 
variability in its perception. (1) The commonly employed methods of pain relief in 
labour  include  systemic  analgesics,  inhalational  anaesthetics,  and  regional 
techniques.  Pethidine  is  the  most  commonly  used  systemic  analgesic  which 
provides moderate analgesia, but it causes sedation, nausea and vomiting in the 
mother and respiratory depression in the neonate. (2) Inhalation of a mixture of 
nitrous  oxide  and  oxygen  (Entonox)  provides  analgesia,  but  it  requires  good 
maternal  co-operation  to  be  effective.  (3)  An  epidural  local  anaesthetic  with 
opioids  provide  good  relief  of  pain  during  labour,  but  is  associated  with 
prolongation  of  the  second  stage  of  labour  and  an  increased  incidence  of 
instrumental  vaginal  delivery.  (4)  It  is  also relatively expensive and needs an 
expert to initiate the block.
Ketamine is a short  acting anesthetic with excellent analgesic property, 
and has been widely used for short surgical procedures like wound suturing and 
dressing in the out patient department. It has been safely used in obstetrics as an 
induction  agent  for  caesarean  section,  manual  removal  of  placenta,  and  for 
forceps delivery. (5) It has been shown that in low doses, intravenous ketamine 
provides good intraoperative and postoperative analgesia. (6, 7) 
This prospective interventional study was an effort to evaluate the efficacy of low 
dose ketamine as a labour analgesic, thereby providing a safe and inexpensive 
alternative,  especially  for  the  developing  countries with  limited  resources and 
economical constraints.
AIM
The aims of this study are:
1. To  evaluate  the  efficacy  of  low  dose  intravenous  ketamine  in  providing 
analgesia during labour.
2. To assess the safety of low dose intravenous ketamine on the parturient and 
the fetus, and its effect on the progress of labour.
3. To standardise a “low dose ketamine” regimen for labour analgesia. 
REVIEW OF LITERATURE
To the woman He (God) said, “I will greatly increase your pains in childbearing, 
with pain you will give birth to children.” Genesis 3:16
SEVERITY OF LABOUR PAIN
 Pain during childbirth may be the most painful experience for a woman. 
Melzack et al, using the McGill pain questionnaire, tried to assess the pain during 
the first stage of labour. Sixty percent of the women described the pain of uterine 
contractions as being extremely severe and unbearable, while the rest described 
it as being moderately severe. (1) Pain during labour was graded higher than that 
during several pain syndromes like backache, phantom limb, fracture and deep 
laceration. It just falls short of the pain experienced during amputation of a digit 
without anaesthesia. (Figure - 1)
Figure 1- Comparison of pain scores, using the McGill  Pain Questionnaire. (PRI - pain rating 
index)From Ward ME, Cousins MJ: Pain Mechanisms in Labor. In Birnbach DJ, Gatt SP, Datta S 
(eds): Textbook of Obstetric Anesthesia. New York: Churchill Livingstone; 2000:3-30.
PATHWAY OF LABOUR PAIN
Pain  during  the  first  stage  of  labour  is  primarily  due  to  the  uterine 
contraction and cervical dilatation. These visceral pain sensations are conveyed 
by the Aδ and C fibers that accompany the thoracolumbar T10 –L1 sympathetic 
outflows. (9)
The second stage of labour pain is due to dilatation of  the cervix  and 
stretching  of  the  perineum  and  the  birth  canal.  This  somatic  sensation  is 
conveyed by the pudendal nerves (S2-4) and is intense and sharply localized. 
(Figure -2)
 
Figure 2- Schematic of the peripheral nociceptive pathways involved in the pain of child birth. 
(From Ward ME, Cousins MJ: Pain Mechanisms in Labor. In Birnbach DJ, Gatt SP, Datta S (eds): 
Textbook of Obstetric Anesthesia. New York: Churchill Livingstone; 2000:3-30)
CHARACTERISTICS OF LABOUR PAIN
There is a lag period between the start of the uterine contraction and the 
perception of pain, which heightens to a peak before the uterus relaxes.(1) This 
lag period is around 20sec in the early first stage, which gradually reduces to 
about  5sec during the second stage.  (Figure-3)  The frequency of  the uterine 
contraction and the pain increases with the progress of labour.
Figure 3- Relation between duration of uterine contraction and duration of pain associated with 
the contraction. (From Ward ME, Cousins MJ: Pain Mechanisms in Labor. In Birnbach DJ, Gatt 
SP, Datta S (eds): Textbook of Obstetric Anesthesia. New York: Churchill Livingstone; 2000:3-30)
EFFECT OF PAIN ON THE MOTHER AND FETUS
The  pain  during  labour  evokes  a  generalized  neuroendocrine  stress 
response  that  has  widespread  physiological  effects  on  the  parturient.  These 
include delayed gastric emptying, un-coordinated uterine contractions, increased 
oxygen  consumption  and  anaerobic  metabolism.  The  sequelae  of 
hyperventilation,  increased  oxygen  consumption,  secretion  of  stress  related 
hormones  can  lead  to  metabolic  acidosis  in  the  mother  and  the  fetus  with 
resultant fetal hypoxia and abnormal fetal heart rate patterns. Effective pain relief 
has been shown to prevent, obtund or abolish these effects. (11)
    METHODS OF PAIN RELIEF
Non-pharmacological techniques such as TENS, acupuncture, massage, 
aromatherapy and hypnosis have been used but the pharmacological methods 
are the main stay of labour analgesia.(3)
The ideal labour analgesic technique should dramatically reduce the pain 
during  labour,  while  allowing  the  parturient  to  actively  participate  in  the 
experience. In addition, it should have minimal effect on the fetus or the progress 
of  labour.  Even  though  a  well  conducted  epidural  blockade  tends  to  nearly 
achieve this, it can be associated with problems and needs expertise to site it, 
which may not be readily available. Hence, systemic narcotics are still the main 
stay for labour analgesia in many parts of the third world where there is an acute 
shortage of trained anesthetists. 
SYSTEMIC ANALGESICS 
Pethidine is the most widely used parenteral opioid for labour analgesia. It 
is a synthetic,  weakly basic, phenylpiperidine derivative and is 28 times more 
lipid  soluble  than  morphine.  The  onset  of  action  is  45  minutes  after  an 
intramuscular injection and the elimination half life is 2.5 -3 hours in the mother 
(12) and 18 - 23 hours in the neonate. (13) Nor-Pethidine, an active metabolite of 
pethidine, is a potent respiratory depressant. Pethidine and nor-pethidine, cross 
the placenta by passive and active diffusion and achieves equilibrium in the fetus 
within 6 hours after maternal administration. Since pethidine is a weak base and 
gets more ionised in an acidic medium, the fetal  concentration is higher than 
maternal levels. (3) Pethidine causes delay in uterine contraction when given in 
the early phase of labour,  but  has no effect  on the progress of  labour when 
administered in the active phase. (14) It decreases fetal heart rate variability and 
the  residual  depressant  effects  are  demonstrated  by  low  Apgar  scores  and 
decreased oxygen saturation in the new born, which persists for several hours 
after delivery. (2) Pethidine causes nausea, vomiting, confusion and sedation in 
the  mother  while  nor-pethidine,  which  has  convulsant  properties  may  be 
contraindicated  in  those  with  severe  pregnancy  induced  hypertension.  (3) 
However, pethidine is still popular as it is inexpensive, readily available, easy to 
administer and has reasonable analgesic effect.
Morphine and fentanyl has also been used for labour analgesia but they 
cause increasing sedation with repeated doses. It has been argued that narcotics 
merely provide sedation rather than analgesia in labour. (15)
INHALATIONAL ANAESTHETICS
Subanaesthetic concentration of an inhalational anesthetic agent, (trilene, 
nitrous oxide, isoflurane) can relieve pain during the first and second stage of 
labour. Entonox, a mixture of 50% nitrous oxide in oxygen has been used since 
1990.  (3)  Nitrous  oxide  has  a  low  blood  gas  solubility  coefficient  and  it 
equilibrates rapidly with blood. The technique of use is important for entonox to 
be effective. It takes approximately 10 breaths or 50 seconds to achieve a near 
maximal  effect.(3)  Therefore  the  parturient  needs  to  be  trained  to  time  the 
maximum  effect  to  peak  contraction  pain.  There  are  conflicting  reports 
concerning the efficacy of entonox as a labour analgesic. Apart from effective 
blood gas concentration, other factors such as distraction, relaxation, and sense 
of control derived from self administration, may explain why a small randomised 
control  trial  by  Carstoniu  showed  no  difference  between  entonox  and 
compressed air  in  early  labour  (16)  However,  prolonged use of  entonox can 
cause  disorientation  and  headache  in  the  mother.  Some  women  may  try 
hyperventilation to improve analgesia, resulting in maternal alkalosis which can 
reduce uterine blood flow.
REGIONAL TECHNIQUE
Epidural and combined spinal  epidural  analgesia perhaps, provides the 
most effective pain relief among the currently available techniques and its use 
has  been  increasing  dramatically  over  the  last  20  years.  However,  epidural 
analgesia has been associated with a number of side effects during labour and 
delivery.  Liebermann et al, did a systematic review of literature examining the 
maternal  and fetal  effects of  epidural  analgesia.  They concluded that there is 
sufficient  evidence  to  show  that  epidural  is  associated  with  a  lower  rate  of 
spontaneous vaginal delivery, a higher rate of instrumental vaginal delivery and a 
longer duration of labour, particularly in nulliparous women.(4)
Howell et al, in a systemic review of 21 studies, to assess the effects of 
epidural analgesia on the mother and the baby, when compared to non-epidural 
analgesia, have concluded that parturients in the epidural group had good pain 
relief,  but were exposed to an increased risk of instrumental  vaginal delivery. 
They did not find any significant difference in the rate of cesarean section or 
Apgar scores. (17)
 The  practical  problems  with  epidural  analgesia  are  that,  it  needs  an 
expert  to  initiate  the  block  and  the  kit  is  expensive.  Close  hemodynamic 
monitoring of the mother and the fetus is required especially during the initiation 
and subsequent bolus top-ups.
KETAMINE
Ketamine  is  a  short  acting  intravenous  anesthetic  agent  with  good 
analgesic property. It does not cause cardiovascular or respiratory depression, 
and it preserves pharyngeal and laryngeal reflexes. It is readily available and is 
relatively  inexpensive.  It  is  being  widely  used  for  short  procedures  such  as 
dressings and suturing in the outpatient department. (5) 
Ketamine,  a  phencyclidine  derivative  was  synthesized  in  1962,  by 
Stevens, and first used in 1965, by Corssen and Domino. (18) Ketamine causes 
dissociative  anesthesia  by  depressing  the  cerebral  cortex  and  activating  the 
limbic  system and the brainstem.(19,  20)  It  acts  at  multiple  sites namely,  N-
Methyl D-Aspartate (NMDA), opioid, adrenergic, and serotonergic receptors. The 
profound analgesic action appears to be due to NMDA receptor antagonism. (21, 
22)
N-Methyl  D-Aspartate (NMDA) receptor is an ionotropic receptor that is 
activated by glutamate which is the most abundant excitatory neurotransmitter in 
the central nervous system. (Figure-4) It requires glycine as a co-agonist and is 
inhibited  by  Mg2+ in  a  voltage  dependant  manner.  The  receptor  channel  is 
permeable to Ca2+ and to a lesser degree to Na+ and K+. Ketamine binds to the 
phencyclidine  receptor  in  the  NMDA  channel  and  inhibits  its  activation  by 
glutamate, in a competitive manner (21) 
Figure-4  Structure of N-Methyl D Aspartate receptor
Ketamine  contains  a  chiral  centre,  producing  two  optical  isomers  or 
enantiomers. The racemic mixture, which is currently available, contains equal 
amounts of the two isomers. (Figure-5) The analgesic potency of the S-form has 
been shown to be 2-3 times more than the R-form while the psychomimetic side 
effects are seen more with the R-ketamine. (21, 23) However, S- ketamine is 
currently not available in India. 
Figure – 5  Isomers of ketamine
Ketamine in anaesthetic doses (2-2.5 mg.kg-1 intravenously) causes tachycardia, 
hypertension, increased salivation and emergence phenomena which includes 
unpleasant dreams, delirium and hallucinations. (5) These psychomimetic side 
effects  can be minimised by the  administration  of  a  benzodiazepine.  In  sub-
anaesthetic  doses (less  than 0.25mg.kg-1`)  it  is  a  potent  analgesic,  while  the 
above mentioned side effects are less. 
Ketamine has a relatively short distribution and elimination half life. The α 
elimination phase lasts for few minutes and the β elimination phase for 2-3 hours. 
It is metabolized extensively in the liver by the hepatic cytochrome P450 enzyme 
system. Its primary metabolite, nor-ketamine, is only one third as potent as the 
parent drug, and the metabolites are excreted by the kidney. (5, 18)
KETAMINE IN OBSTETRICS
Ketamine has been used in obstetrics for  manual  removal  of  placenta, 
instrumental delivery, breech delivery and as an induction agent for caesarean 
section.  It  has  been  reported  that  Chodoff  and  Stella  (24)  were  the  first  to 
introduce  ketamine  as  a  labour  analgesic.  They  used  a  bolus  dose  of 
0.15mg.kg-1over 1 minute followed by an intravenous infusion. 
Downing  et  al,  studied  50  full  term  parturients  planned  for  elective 
caesarean  section.  Anaesthesia  was  induced  with  ketamine  2mg.kg-1 and 
maintained with  nitrous oxide and oxygen.  The maternal and fetal  cord blood 
samples  were  analyzed  for  pH  and  PO2 values.  The  anaesthesia  was 
satisfactory, with no hemodynamic changes and without undue depression of the 
new  born.  The  short  duration  of  action,  apparent  lack  of  accumulation  and 
satisfactory anesthetic effect suggest that ketamine is a safe alternative as an 
induction agent for caesarean section. (25) 
Bernstein  et  al,  compared  thiopentone  and  ketamine  (1mg.kg-1)  as  an 
induction agent for caesarean section. Maternal pH was found to be higher in the 
ketamine group compared to the thiopentone group. There was no difference in 
the neonatal pH and PCO2 values, or the Apgar score in both the groups. They 
concluded  that  ketamine  can  be  safely  used  as  an  induction  agent  in  the 
recommended dose of 1mg.kg-1 and is a good alternative to thiopentone. (26) 
Dieh – Nielson and Holasek used 1.2mg.kg-1 of ketamine as an induction 
agent  in  100  term  parturients  undergoing  caesarean  section.  They  found 
excellent  Apgar  scores  in  all  neonates  and  only  3  mothers  had  unpleasant 
dreams. (27)
KETAMINE AND UTERINE TONE
Marx et al studied the effect of 4 different doses (25, 50, 75, 100 mg) of 
ketamine  on  postpartum  uterine  pressures.  In  twenty  two  women,  who  had 
normal  vaginal  delivery,  a  baseline  uterine  pressure  was  measured  after  the 
expulsion  of  the  placenta.  The  four  different  doses  of  ketamine  were  given 
intravenously at intervals, and the intrauterine pressure was measured after each 
dose. Ketamine in the dose of 25mg (0.3 -0.5 mg.kg-1) did not alter the contractile 
pattern,  whereas,  50mg (0.6-1mg.kg-1)  caused an increase in  the  intensity  of 
individual uterine contractions similar to oxytocin. Doses of 75mg (1.0-1.2mg.kg-1) 
and 100mg (1.3-1.8mg.kg-1) caused an increase in the intensity and frequency of 
contractions. There was no increase in the resting uterine tone with any of the 
above doses. They recommended that the dose of ketamine for labour analgesia, 
during vaginal delivery should not exceed 0.3 - 0.5 mg.kg-1. (28)
Craft et al investigated the effect of ketamine, on the maternal and fetal 
cardiovascular  variables,  uterine  blood  flow,  uterine  tone  and  the  possible 
transfer of ketamine across the placenta. The study was done on 8 pregnant 
term  ewes.  Ketamine  0.7mg.kg-1 was  given  intravenously  over  30  minutes. 
Maternal and fetal arterial samples for blood gas analysis were taken at 1, 3, 5, 
10, 15, 30, 45 and 60min after the injection. Ketamine and catecholamine levels 
were also measured. Maternal ketamine values peaked after 1 minute, declined 
rapidly  over  the  first  5  minutes  and  slowly  over  60  minutes.  There  was  no 
significant increase in nor-epinephrine and dopamine levels following ketamine 
bolus. The mean blood pressure and the cardiac output increased by 7% and 
16% respectively at 5 minutes and returned to baseline by 15 minutes. There 
were no significant changes in the uterine blood flow or the acid base values. 
Fetal  ketamine levels  peaked within  1 minute and declined within  30minutes. 
There was no significant change in the hemodynamics, blood gas values or the 
catecholamine levels in the fetus. (29)
Strumper et al studied the effect of S (+) Ketamine on the uterine blood 
flow. Equianalgesic doses of S (+) ketamine (10mg.kg-1.hr-1) or racemic ketamine 
(20mg.kg-1.hr-1) were infused into 12 pregnant sheep. The maternal and fetal vital 
signs,  blood  gases  and  uterine  blood  flow  were  recorded  over  2hours.  The 
uterine perfusion and the maternal and fetal hemodynamics were not affected by 
either  compound.  Racemic  ketamine increased the  maternal  and fetal  PCO2, 
while S- ketamine did not. The authors have suggested the use of S- ketamine 
as an analgesic adjuvant in the obstetric setting. (30) 
KETAMINE FOR LABOUR ANALGESIA
Galloon et al conducted a study to evaluate the oxytocic effect of ketamine 
on pregnant uterus. The study was done on 5 ASA–1 patients having abdominal 
hysterotomies for termination of pregnancies. Once the uterus was exposed, a 
trochar was inserted into the amniotic cavity and the baseline uterine pressures 
were  measured.  Four  different  doses  of  ketamine  were 
administered-0.275mg.kg-1,  0.55mg.kg-1,  1.1mg.kg-1,  2.2mg.kg-1.  Ketamine  in 
doses of 1.1 mg.kg-1 or less increased the intensity of uterine contractions, while 
larger  doses,  in  addition  to  increasing  the  intensity  of  uterine  contractions, 
increased the basal uterine tone in between contractions.(24)
Sarkar and Sahu used ketamine as a continuous intravenous infusion for 
labour analgesia in 50 pregnant women. A bolus of 0.2 to 0.4 mg.kg-1 of ketamine 
at the onset of active labour was followed by an infusion of 0.5-1.0mg.min-1. The 
total dose used was 220-540mg in the primigravida women and 100-320mg in 
the  multigravida  women.  35  women  had  excellent  analgesia  while  7  had 
hallucinations.  The  progress  of  labour  was  unhampered  and  the  mean  1min 
Apgar score was more than 8. (31)
Gangla et al used boluses of ketamine in 50 full term pregnant women. 
The  initial  loading  dose  was  0.5mg.kg-1 followed  by  0.25mg.kg-1 every 
20-30minutes.  The  average  total  dose  used  was  200mg  and  they  reported 
satisfactory analgesia  in  72 % of  parturients.  All  the neonates had an Apgar 
score of more than 8 and 98% of patients delivered within 5hrs. However, fifty 
four percent of the parturients had hallucinations. (32)
KETAMINE FOR POSTOPERATIVE PAIN
Ketamine has been administered as a low dose infusion for its analgesic 
effect  during  various  surgical  procedures  and  in  the  post  operative  period. 
Snijdelaar  et  al  used  S  (+)  ketamine  in  patients  undergoing  radical 
prostatectomy.  The patients  were randomized to receive either  ketamine in a 
dose of 0.1mg.kg-1 bolus intravenously followed by an infusion of 0.002mg.   kg-1. 
min-1 or saline as placebo. Postoperatively,  the patients in the ketamine group 
received  patient  controlled  analgesia  containing  morphine  (1mg  per  bolus) 
combined with ketamine (0.5mg per bolus), while the patients in the saline group 
received patient controlled analgesia containing only morphine.  Patients in the 
ketamine group demonstrated a significant drop in opioid requirement during the 
postoperative  period.  The  pain  scores  at  rest  were  significantly  lower  in  the 
ketamine group across the 48hr study period. (6)
Guignard et al studied 50 patients scheduled for colorectal surgery under 
remifentanil based anesthesia. They were randomly assigned to receive either 
intraoperative  ketamine  in  a  dose  of  0.15mg.kg-1 followed  by  an  infusion  of 
0.002mg.kg-1 or  saline  as  placebo.  Remifentanil  infusion  was  used  for 
intraoperative  analgesia.  All  patients  were  given  morphine  for  post  operative 
analgesia. The dose of remifentanil that was required in the ketamine group was 
less  compared  to  that  in  the  control  group.  Patients  in  the  ketamine  group 
received less morphine compared to those in the control group during the first 24 
hours of the post operative period. (7)
PATIENTS AND METHODS
This interventional study was a prospective evaluation conducted in the labour 
room of a tertiary referral hospital after obtaining approval from the Research and 
Ethics committee of the institution. 
METHODOLOGY
Parturients  with  no antenatal  risk factors and expected to have normal 
vaginal delivery were eligible to be included in the study.  Women with known 
cardiac disease, gestational hypertension, epilepsy or known psychiatric disorder 
were  excluded,  as  were  parturients  with  multifetal  pregnancy,  suspected 
cephalopelvic  disproportion  and  those  who  have  had  previous  caesarean 
section. 
STUDY INTERVENTION
 All  the  parturients  eligible  for  the  study  were  explained  about  the 
procedure and a written consent obtained from the volunteers. 
A 20G intravenous cannula was inserted into the forearm which was used 
only  for  the  infusion  of  ketamine.  Racemic  ketamine  (Aneket®,  Neon 
Laboratories) was loaded in a 50ml syringe in a concentration of 2mg.ml-1and 
connected to this intravenous cannula. A bolus dose of 0.1mg.kg-1 of ketamine 
was administered. This was followed by an infusion of ketamine at the rate of 
0.2mg.kg-1.hr-1 .The  rate  of  the  infusion  was  adjusted  according  to  the  pain 
perceived by the parturient during the uterine contraction and was altered as and 
when required. The infusion was stopped after the baby was delivered.
MONITORING
The  baseline  parameters  of  the  parturient  such  as  the  heart  rate,  the 
systolic  and diastolic  blood pressure,  the  pain  score,  the sedation score,  the 
duration  and  frequency  of  uterine  contractions  and  the  fetal  heart  rate  were 
recorded.  These  parameters  were  continuously  recorded  at  regular  intervals 
during the study period. 
The  patients  were  asked  to  grade  the  severity  of  their  pain  during 
contractions, on a Visual Analogue Scale from 0-10, with 10 being severe.
The sedation was graded on a 4 point scale as,
0 - Awake
1- Drowsy, but responsive to verbal stimuli
2– Drowsy, but responsive to physical stimuli
3– Unresponsive to physical and verbal stimuli  
The duration of the second stage, the type of delivery, the amount of blood 
loss and any complications during the third stage were noted. Side effects like 
vomiting,  hallucinations,  unpleasant dreams, nystagmus and light headedness 
were also looked for and recorded.
The newborn was clinically assessed by a neonatologist. The Apgar score 
at 1 and 5 min after birth, and the pH of the umbilical cord blood were recorded. 
The parturients were interviewed by the investigator  a  couple of  hours 
after the delivery and were asked to grade their perception of the pain relief and 
their satisfaction with the overall care on a scale 0-10, with 10 being excellent. 
The obstetricians were asked to comment on this study intervention, with 
regard to efficacy of ketamine as a labour analgesic, its affect on the progress of 
labour and maternal co-operation during delivery. The mother and the baby were 
observed for 48hrs after delivery or till the time of discharge from hospital.
The following variables were recorded during the study period and analysed.
Total duration of labour, duration of second stage
Total dose of ketamine required and the rate of infusion per hour
Pain score
Type of delivery
Side  effects  in  the  parturient  such  as,  sedation,  nausea  and vomiting, 
unpleasant dreams, nystagmus and light headedness
Maternal  hemodynamic  parameters  such  as  the  heart  rate  and  blood 
pressure and their fluctuations from the baseline
Neonatal assessment
Patient’s satisfaction with regard to relief of pain and the overall care
Obstetrician’s comments.
STATISTICS
Since, continuous infusion of low dose ketamine has not been used during 
labour before, this pilot study was undertaken to assess its efficacy as a labour 
analgesic and to standardise a regimen. It was decided to do the initial evaluation 
on 30 parturients,  and then ratify  the dose regimen in  a  larger  population,  if 
ketamine was found to be effective. The results of the pilot study on 30 patients 
are presented.
The statistical analysis was done using the Statistics Package for Social 
Sciences (SPSS® version 11).
RESULTS
Thirty  parturients  in  active  labour  were  consented to  participate  in  the 
study. The characteristics of the patients are described in Table -1.
Table -1 The demographic details of the patients
in the study population
Age (yrs)
Mean ± SD 24.5 ± 4.0 (Range 17 – 31 )
Weight (kg )
Mean ± SD 65.1 ± 8.7 ( Range 51 – 85 )
Gravida
Primigravida     – 12
Multigravida      - 18
Onset of labour
Spontaneous – 16
Induced         - 14
DURATION OF LABOUR
The duration of labour for each parturient was recorded, as the time from 
the onset of active labour to the delivery of the baby. This was 260 ± 167min in 
the  study  group,  with  it  being  longer  in  the  primigravida  (307  ±  150min)  as 
compared to the multigravida (200 ± 175min). This difference was statistically 
significant (p =0.005). The duration of labour was shorter in those parturients who 
had a spontaneous onset of labour(239 ± 160min) as compared to those who 
had to have their  labour  induced (304.35 ± 163.5min) although,  this  was not 
statistically significant (p=0.166). 
DURATION OF SECOND STAGE
The duration of second stage namely, the time from the full dilatation of 
the cervix to the delivery of the baby was 38 ± 35.2min. This was longer in the 
primigravida women (46.2 ± 33.2 min) as compared to the multigravidae (29.5 ± 
36.9 min) and was statistically significant  ( p= 0.037 )
TYPE OF DELIVERY
Of the 30 women who participated in the study, 21 (70 %) had normal 
vaginal delivery, 6 (20%) had assisted delivery and 3 (10%) had to be delivered 
by  caesarean  section.  The  indications  for  caesarean  section  were  arrest  of 
cervical dilatation in one and non-reassuring fetal status, in the other two. Of the 
women who  had  assisted  delivery,  2  had  prolonged  second  stage  (145  and 
116min), while the others had non-reassuring fetal status.
 All the 3 women who had caesarean section and 5 out of 6 women who 
had assisted delivery were primigravida. 
BLOOD LOSS 
The average blood loss during delivery in the study group was 184.17 ± 
85 ml with it being 206.9 ± 86.5ml in the primigravida and 150.0 ± 73.8ml in the 
multigravida. This was statistically significant (P = 0.007). None of the parturients, 
included in the study had postpartum hemorrhage.
PAIN SCORE
During  the  course  of  labour  the  parturients  were  asked  to  grade  the 
severity of their pain on a visual analogue scale with scores from 0-10 and this 
was  recorded  at  hourly  intervals.  All  the  parturients  experienced  adequate 
analgesia within 1-2hrs of administration of ketamine infusion as shown in figure 
-6.
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Figure – 6. Pain score at hourly intervals during the study. N denotes the 
number of patients at each hour.
INTRAPARTUM REQUIREMENT OF KETAMINE
The total dose of ketamine required by each parturient was calculated and 
the average dose was found to be 57 ± 37.5mg (range 18-160mg). The infusion 
rate of ketamine during the course of labour was also calculated and the average 
infusion required was 0.17 ± 0.06mg.kg-1.hr-1 (range 0.08-0.32).
Table –2 The dose of ketamine and gravida
Gravida Primigravida Multigravida p value
Total (mg) 68.5 ± 35.9 39.6 ± 34.2 0.002
Average 
(mg.kg-1.hr-1)
0.18 ± 0.06 0.16 ± 0.05 0.5
Although the total dose of ketamine required among the primigravida was 
significantly more than that required for the multigravida, this was not so when 
the infusion rates were compared. (Table -2) 
Table –3 The dose of ketamine and onset of labour
Onset of labour Spontaneous Induced p value
Total (mg) 45.5 ± 33.1 70.14 ± 39.1 0.02
Average 
(mg.kg-1.hr-1)
0.16 ± 0.06 0.19 ± 0.06 0.20
The parturients who had a spontaneous onset of labour required a lower 
dose of ketamine when compared to those who had induction of labour (p=0.02) 
However, the rate of infusion, did not differ between these two groups. (Table -3) 
INFUSION RATE OF KETAMINE
The infusion of ketamine was started immediately after the bolus dose. 
The infusion was initially started at the rate of 0.2mg.kg-1.hr-1 and was adjusted 
based  on  the  pain  perceived  by  the  parturient.  The  infusion  rate  had  to  be 
increased  in  the  initial  couple  of  hours  and  was  reduced  by  the  third  hour. 
(Figure-7)
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Figure -7   The infusion rate of ketamine at hourly intervals. N denotes the 
number of parturients at each hour.
RESCUE ANALGESIC
According  to  the  study  protocol,  any  parturient  who  did  not  achieve 
adequate  analgesia  with  ketamine  were  to  be  administered  an  intramuscular 
dose of Pethidine (50mg) and Promethazine (25mg). This rescue analgesic was 
needed in only one parturient.
COMPLICATIONS
Ketamine  is  known  to  cause  side  effects  such  as  hallucinations, 
unpleasant  dreams,  nystagmus,  light-headedness,  nausea  and  vomiting. 
Therefore, these complications were looked for in all the parturients in the study.
None of the women had hallucinations or unpleasant dreams. 2 women 
had  vomiting  but  they  had  episodes  of  vomiting  before  the  ketamine 
administration was started, and there was no worsening of symptom.
Immediately following the administration of the bolus dose of ketamine, 16 
women complained of light headedness which lasted for about 3-5min, and 7 
women had  jerky,  to  and  fro  movement  of  their  eyeballs  (nystagmus)  which 
lasted for nearly a minute. These findings did not recur during the study period 
when the ketamine infusion was being administered.
Since ketamine causes sedation, the level of wakefulness was graded on 
a four point  scale during the study period. All  the women were awake during 
labour, except for 8 women who were drowsy but responded to verbal stimuli 
(Grade 1).
HEMODYNAMIC CHANGES
Since  intravenous  administration  of  ketamine  causes  transient 
sympathetic stimulation, the heart rate and the blood pressure were monitored 
during the first one hour after the administration of the bolus dose of ketamine.
CHANGES IN THE HEART RATE
The baseline heart rate was 84.56 ± 4.6 beats per minute and there was a 
clinically insignificant increase in heart rate (4.96%) above the baseline value and 
this was seen within 10min after the bolus dose. (Figure – 8)
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Figure – 8 The heart rate (mean and 95% Confidence interval) during the 
initial one hour of study intervention. 
CHANGES IN THE BLOOD PRESSURE
The baseline systolic and diastolic blood pressure was 118.4 ± 8.9mmHg 
and 76.8 ± 6.8mmHg respectively. There was a clinically insignificant increase in 
the systolic (5%) and diastolic (6.3%) blood pressure above the baseline and this 
was observed soon after the bolus dose.              (Figure-9)
70
75
80
85
90
95
100
105
110
115
120
125
Baseline After Bolus 10min 30 min 60 min
B
lo
od
 P
re
ss
ur
e 
m
m
H
g
Systolic Diastolic
Figure - 9 Systolic and diastolic blood pressure (mean and 95% confidence 
interval) during the initial one hour after the bolus dose of ketamine. 
FETAL HEART RATE
The fetal heart rate was monitored throughout the study period. There was 
a drop in the fetal heart rate of about <5 beats per minute after the bolus dose of 
ketamine. However, this was not clinically significant. (Figure -10)
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Figure – 10 The fetal heart rate (mean and 95% confidence interval) during 
the initial one hour after the bolus dose of ketamine. 
ASSESSMENT OF THE NEW BORN
All the neonates were assessed by a neonatologist at birth. The Apgar 
score at the first and fifth minute of birth, and the pH of the cord blood were 
recorded.
NEONATOLOGIST’S ASSESSMENT
 Three babies were found to be clinically depressed at birth. Two of them 
had irregular respiratory efforts which improved with gentle throat suctioning and 
mask  ventilation  with  oxygen.  One  neonate  was  floppy  at  birth  with  severe 
respiratory depression and required intubation and assisted ventilation for 1min, 
after  which  the  respiratory  efforts  became  regular  and  was  extubated.  Five 
neonates  were  transfered  to  the  nursery  for  observation.  Of  these,  3  were 
delivered by caesarean section, one had an Apgar score of 1 at the first minute 
of birth but recovered later, and the mother of the fifth neonate had an altered 
glucose tolerance  test  and  a  history  of  early  neonatal  death  during  previous 
pregnancy. 
APGAR SCORE
The Apgar score of two neonates were less than 8 at the first minute but 
they improved, and all had a score of more than 8 at 5 minutes. (Table-4)
Table – 4 Apgar score at 1min and 5min
Score <8                            ≥8
1 min 2                                 28
5 min 0                                 30
pH OF CORD BLOOD
A sample of blood was taken from the umbilical artery of the neonate for 
blood gas analysis. The pH ranged from 7.05–7.35 with a mean of              7.207 
± 0.007.
PATIENT’S SATISFACTION
The parturients were interviewed within couple of hours of delivery and 
asked to  comment  on  their  perception  of  the  degree  of  pain  relief  and their 
satisfaction with the overall care.
All the parturients graded the level of analgesia as a percentage relief of 
pain.  Twenty seven (90%) graded the level  of  pain relief  as more than 50%. 
However, when asked about their satisfaction with the overall care, on a scale of 
0-10,  25(83.3%) graded it  as  good while  5  (16.6)  were  moderately  satisfied. 
(Table-5)
Table – 5 Satisfaction score
Score 0-3
(Poor)
4- 6
(Average)
≥7
(Good)
No. of 
Patients 0 5 25
OBSTETRICIAN’S COMMENT
The obstetrician was asked to comment on various aspects of the study 
such as, the adequacy of pain relief, the effect on the progress of labor, maternal 
co-operation during delivery and any side effects. 
They were satisfied with the relief of pain in 26 of the 30 women. They did 
not feel that the progress of labour was affected in any way except in 2 women 
who had prolonged second stage. All the mothers co-operated well during the 
second stage and all of them were fully awake except two who had to be called 
to awaken.
DISCUSSION
Pain during childbirth is graded as severe by most women, although there 
is a considerable variation in its perception. The characteristic of labour pain is 
that it  is intermittent and it  increases in intensity and frequency as the labour 
progresses. An ideal labour analgesic should be safe to the parturient and the 
neonate, easy to administer, readily available, inexpensive and with no untoward 
effect on the progress of labour.
Ketamine  is  a  short  acting  intravenous  anaesthetic  with  excellent 
analgesic property. It has been widely used in outpatient departments for short 
and painful procedures like wound suturing, change of dressing in patient with 
burns,  and  short  surgeries  such  as  incision  and  drainage  of  abscess. 
Perioperative  use of  low dose ketamine infusion  has been shown to  provide 
analgesia and reduce the intraoperative and postoperative narcotic requirement. 
(6, 7)
Ketamine has been safely used in obstetrics since 1966. (24) It’s been 
recommended as an analgesic for forceps delivery, manual removal of placenta 
and as an induction agent for cesarean section. Ketamine, when used in the 
dose of less than 1mg.kg-1 over  30min,  was shown to  have no effect  on the 
progress  of  labour,  the  intra-uterine  pressures,  the  oxygenation  and the  acid 
base status of the fetus. (24, 28, 29, 30)
ANALGESIA AND PATIENT SATISFACTION
This study has shown that low dose intravenous ketamine infusion at the 
rate of 0.17 ± 0.06mg.kg-1.hr-1 provides acceptable labour analgesia in 90% of the 
study patients. The pain score was decreased to an acceptable level within 2hrs 
of starting the infusion. (Figure-6) Of the 3 women who graded low on analgesia, 
one was a primigravida who was induced for post dates and was on a oxytocin 
infusion for augmentation of labour. Ketamine, at the rate of 0.2-0.25mg.kg-1.hr-1 
was infused, but she had only 20% pain relief. Five hours into labour, the fetal 
heart monitor showed a loss of beat to beat variability, and therefore the oxytocin 
and  the  ketamine  infusion  were  stopped.  One  hour  later,  an  intramuscular 
injection of pethidine (50mg) was given. Five hours following this, she delivered 
normally and the baby had an Apgar score of 9 at the first minute and 10 at the 
fifth  minute  of  birth.  The  other  two  patients  were  multigravidae  at  term  with 
spontaneous  onset  of  labour.  They delivered  within  two  and  a  half  hours  of 
starting the ketamine infusion. This short duration of labour could have been the 
cause for them not having had good analgesia, as it takes an average of 2hours 
to achieve good analgesic effect with this infusion rate. However, this lack of pain 
relief did not reflect on their rating of satisfaction with the overall care. This could 
be due to the concern of the investigator during labour and the joy of having a 
healthy baby in their arms.
OBSTETRICIAN’S COMMENTS
The obstetricians felt that out of the 30 women, 26 had good analgesia 
while  4  had incomplete pain  relief.  They also felt  that  the second stage was 
prolonged in 2 of the parturients, both of whom needed outlet forceps to assist 
delivery.  Two  women  were  drowsy  but  arousable  on  calling  their  names 
(sedation score -1). This low dose infusion of ketamine seems to be acceptable 
to  the  obstetricians  since  it  provided  adequate  analgesia  in  most  of  the 
parturients, with them being co operative during delivery and without interfering 
with the progress of labour.
DOSE OF KETAMINE
The dose of  ketamine was found to  be 57 ± 37.5mg and the average 
infusion  rate  was  0.17  ±  0.06mg.kg-1.hr-1.  This  translates  to  a  dose  of  only 
10-15mg per hour. This is much lower than that used in the previous studies (31, 
32). The total dose of ketamine was more in the primigravida women, since the 
duration of labour was longer, but the infusion rate per hour was similar, thereby 
suggesting that the analgesic requirement is similar in both. The parturients who 
had a spontaneous onset of labour required less ketamine when compared to the 
women who had their labour induced. Augmentation of the uterine contractions 
with oxytocin could be the reason for this.
EFFECT ON THE PROGRESS OF LABOUR
Although the obstetricians commented that  two patients  had prolonged 
second stage,  the average duration of  second stage was 46.2 ± 33.2min for 
primigravida  women and  29.5  ±  36.9min  for  multigravida  which  is  within  the 
acceptable limits.  (33)  Similarly,  the  duration of  labour  was  307 ± 150min in 
primigravida  and  200  ±  175min  in  multigravida  which  are  also  within  the 
acceptable limits.  (33)  Ketamine is  shown to  have oxytocic  effect  and in  low 
doses,  it  increases the  intensity  of  uterine  contractions  while  maintaining  the 
basal uterine tone (24, 29). This could theoretically shorten the duration of labour 
and this  was  evident  in  this  study  population.  This  is  in  contrast  to  epidural 
analgesia, which has been shown to prolong the second stage. (4)
In this study, the incidence of caesarean section was 10% which is less 
than the  prevailing  incidence of  25-30% among the  population  attending  this 
tertiary referral institution. The indication for caesarean section were, arrest of 
cervical  dilatation  in  one  and  non-reassuring  fetal  status  in  the  other  two 
parturients.  Of  the  6  parturients  who  had  assisted  delivery,  2  of  them  had 
prolonged second stage (140 and 116 min) and the rest had non-reassuring fetal 
status. The incidence of assisted delivery in this study was 20% which is within 
the current incidence of instrumental delivery of this institution.
The blood loss in the study group was minimal (184.17 ±85ml). None of 
the women had postpartum hemorrhage probably reflecting the oxytocic action of 
ketamine.
SIDE EFFECTS OF KETAMINE
Intravenous  administration  of  a  bolus  dose  of  ketamine  causes 
sympathetic  stimulation  with  an  immediate  increase  in  heart  rate  and  blood 
pressure. This was not observed in the study population possibly due to the low 
dose of ketamine used.
The  use  of  a  larger  dose  of  ketamine  (2mg.kg-1)  causes  emergence 
phenomena. (16) Sarkar et  al  (31) used the dose of 0.2-0.4mg.kg-1 as bolus, 
followed by an infusion of 0.5-1.0mg.min-1 which approximated to 1mg.kg-1hr-1. 
and they reported 14% of their study patients to have hallucinations. Gangla et al 
(32) although having used only 0.5-0.6mg.kg-1.hr-1, had high incidence (54%) of 
hallucinations, thereby suggesting that emergence phenomena could be related 
to peak levels of ketamine. This was not observed in this study population as a 
lower dose was given as an infusion rather than as bolus. Benzodiazepine was 
avoided in the study for the fear of sedation and non-participation of the mother 
during labour. None of the women were sedated to be un-cooperative during the 
second stage. 
 However, the administration of the bolus dose did cause a sensation of 
light  headedness in  16  patients  lasting  for  less  than five  minutes  and seven 
parturients had a vacant gaze with a slow nystagmic movement of the eyeball 
which lasted for about a minute. This may suggest that these side effects could 
be  avoided  or  minimised  if  this  dose  was  administered  over  a  period  of 
15-30minutes.
Sarkar  et  al  (31)  have described an incidence of  14% of  nausea and 
vomiting with the use of ketamine for labour analgesia. In this study it was seen 
that  2  women  had  vomiting,  but  they  had  these  episodes  before  the  study 
intervention and there was no worsening of the symptom. 
EFFECT ON THE NEW BORN
Of the 30 babies, 28 had a Apgar score of more than 8 at 1min and all of 
them had a score of 9 and above at 5minutes. Of the two babies who had less 
Apgar score at the first minute, one was born to a primigravida at 40+3 weeks, 
who had her labour induced and was on an infusion of oxytocin for augmentation 
of labour. She had ketamine infusion at the rate of 0.2mg.       kg-1.hr-1 and 
experienced good analgesia within 1hr of the infusion. After 3hrs of the study 
period she had variable  decelerations  of  the fetal  heart  rate  and per  vaginal 
examination  revealed  meconium stained  amniotic  fluid  and  ketamine  infusion 
was stopped. The infusion of  oxytocin  which was also stopped was restarted 
after 2 hrs and she continued to have variable decelerations of the fetal heart 
rate  and  was  delivered  by  outlet  forceps  (4hrs  after  stopping  the  ketamine 
infusion).The  baby was floppy and cyanosed at birth,  and needed intubation 
suctioning and ventilation. However, after 1 min the respiratory efforts became 
regular and the endotracheal tube was removed. The Apgar score at the fifth 
minute was 9 and pH of the cord blood was 7.053. The second neonate was born 
to a multigravida at term, by normal vaginal delivery and had an Apgar score of 6 
at the first minute. Throat suctioning and mask ventilation were done after which 
the respiratory efforts became regular and the Apgar at the fifth minute was 10 
and cord blood pH was 7.084.
The pH of the cord blood was analysed for all neonates and it ranged from 
7.05-7.35 with a mean of 7.20 ± 0.07 which is within the normal recommended 
range, (34) suggesting adequate fetal oxygenation.
All the babies were examined by the neonatologist and 3 of them were 
found to be clinically depressed at birth.  Two babies had irregular respiratory 
efforts which improved with  gentle throat suctioning and mask ventilation with 
oxygen. The third neonate who had severe respiratory depression as described 
earlier, was intubated and ventilated for 1min. Five babies were shifted to the 
nursery. Three of them were babies born by caesarean section and are routinely 
kept for observation for 24 hrs. The other 2 babies included, the one with severe 
respiratory depression at birth (described earlier) and a neonate born to a mother 
with impaired glucose tolerance test and previous early neonatal death
Therefore,  ketamine,  which  is  inexpensive  and  readily  available,  can 
provide good pain relief to the parturients when administered intravenously at the 
rate of 0.15- 0.2mg.kg-1.hr-1. The minor side effects observed, were in relation to 
the bolus dose of 0.1mg.kg-1 given as a loading dose prior to initiation of the 
infusion. Despite this bolus dose, effective analgesia was established only by 
2hours. Therefore, it seems that a higher loading dose should be administered, 
possibly, 0.2-0.4mg.kg-1 but this should be given over a period of 15-30 minutes. 
This  would  mean starting  the  infusion  at  a  higher  rate  of  0.4mg.kg-1.hr-1 and 
reducing it to 0.15-0.2mg.kg-1.hr-1 within 30minutes.
This study has shown that, intravenous low dose ketamine can provide effective 
labour  analgesia.  However,  this  dose  regimen  should  be  ratified  on  a  larger 
population  before  being  recommended  as  a  standard  technique  of  labour 
analgesia. 
CONCLUSION
Although, systemic opioids, inhalational analgesia and regional techniques 
are  widely  used,  effective  control  of  labour  pain  with  a  technique which  has 
minimal side effects on the parturient, the fetus and the progress of labour is yet 
to be found. Ketamine, a NMDA receptor antagonist, is shown to be an excellent 
analgesic. Although it is associated with unpleasant side effects, these can be 
minimised  when  ketamine  is  administered  slowly  in  very  low  doses 
(0.1-0.2mg.kg-1.hr-1) while retaining its analgesic property. 
In  this  study,  ketamine  was  administered  as  a  bolus  of  0.1mg.kg-1, 
followed by an infusion of 0.2mg.kg-1.hr-1  to parturients in active labour and was 
found to provide effective analgesia with minimal side effects. This technique was 
found to  be  acceptable  both  to  the  parturient  and the  obstetrician.  However, 
minor modification to this technique, namely,  a loading dose of 0.4mg.kg-1.hr-1 
given over a period of 30minutes followed by an infusion of 0.15-0.2mg.kg-1.hr-1, 
would ensure rapid onset of analgesia while minimizing the side effects due to 
the bolus administration of the loading dose.
Since,  the  efficacy  and  safety  of  low dose  intravenous  ketamine  as  a 
labour analgesic has been established, a regimen, with slight modification, would 
be ratified on  a larger  population,  before being  recommended as  a standard 
technique of labour analgesia.        
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KETAMINE IN LABOUR ANALGESIA
PROFORMA
TIME OF ONSET OF LABOUR: SPONTANEOUS / INDUCED
DOSE OF KETAMINE BOLUS:
TIME OF THE PRIMING DOSE:
TIME OF STARTING  INFUSION:
SERIAL NO:
DATE
OBST.SCORE
GEST. AGE
NAME
HOSPITAL NO:
AGE
WEIGHT
VARIABLE BAS
ELI
NE
10MI
N
20MI
N
30MI
N
45MI
N
1HR 1.5 
HR 
2 HR 2.5 
HR
3 HR 3.5 
HR
4 HR 4.5 
HR
5 HR
PULSE
B.P
R.R
F.H.R
CX DILATION
STATION
DUR OF 
CONTRACTn
INFUSION 
RATE
PAIN SCORE
SEDATION
INFUSION 
RATE (MG/KG/
HR)
RESCUE ANALGESIA ADMINISTERED-
TIME OF DELIVERY
TYPE OF DELIVERY- NORMAL/ ASSISTED/ LSCS
BLOOD LOSS –
SIDE EFFECTS   
-VOMITING        YES/ NO
-HALLUCINATIONS     YES/NO
-DREAMS            YES/ NO
TIME OF DISCONTINUING INFUSION –
NEONATE --APGAR SCORE      1min                    5min
-CORD BLOOD PH –
-NEONATOLOGIST OPINION-
PATIENT’S RESPONSE – 
• PAIN                    0-------------10
• SATISFACTION 0-------------10
 
OBSTETRICIAN’S COMMENT -
VISUAL ANALOGUE SCALE 0----------------------10
SEDATION SCORE:
0-Awake
1-Responds to verbal call
2-Responds to tactile stimulus
3-Unresponsive
MASTER SHEET
Name Hosp.no age Weight Gravida
Geat. 
Age Onset Bolus
Poomagal 645286C 27 60 M 1 1 6
Priya
728565 
C 20 51 P 1 1 5
Rathna
683453 
C 27 75 P 2 2 7
Kannaki
754478 
C 21 60 P 1 1 6
Sumathi
671342 
C 21 55 P 1 1 5.5
Komathi
450375 
C 27 55 M 1 1 5
Mohana
377570 
C 18 67 M 1 1 7
Parveen
183803 
C 25 60 P 1 1 6
Selvi
729490 
C 29 74 M 1 1 7
Vanitha
776893 
C 21 70 P 2 2 7
Lakshmi
748107 
C 23 60 P 1 2 6
Shanthi
215279 
C 23 62 M 1 1 6
S.Laksmi
737563 
C 30 75 P 1 2 6
Selvi
031652 
C 19 72 M 1 1 7
Rekha
728756 
C 23 55 M 1 1 6
Syeeda B
863619 
B 25 78 M 1 1 8
A. Selvi
784390 
C 30 70 P 1 1 7
Deepa
208655 
C 21 60 M 2 1 6
Usha
824861 
C 23 65 P 2 2 6
Padma
442551 
C 30 60 M 2 1 6
M.Megalai
742716 
C 29 55 P 2 2 5
jothi
784107 
C 25 85 P 2 2 8
T.Sundari
816922 
C 27 53 P 1 2 5
Ramya
726882 
C 17 80 P 1 2 8
Nazeema
727570 
C 28 65 P 1 2 6.5
Malathi
303233 
C 31 60 M 1 2 6
Nalini
234340 
C 21 65 M 1 1 6
Suguna
832293 
C 24 70 P 2 2 7
Tamil
741871 
C 20 75 P 1 2 7.5
Tasneem
832297 
C 30 62 P 2 2 6
1 stage 2-Stage 3-Stage
Cerv. 
Dilat Inf_0.5hr Inf_1hr Inf_2hr Inf_3hr Inf_4hr Inf_5hr
30000.00% 30 5 4 0.2 0.2 0.2 0.2 0.2 0.2
300 75 4 3 0.2 0.3 0.3 0.3 0.3 0.3
300 35 7 3 0.2 0.2 0.3 0.3 0.4 0.2
240 50 4 4 0.2 0.2 0.16 0.1 0.1 0.1
360 3 0.2 0.27 0.29 0.21 0.2 0.2
90 20 4 5 0.2 0.25 0.3
80 5 3 5 0.2 0.23 0.2
155 88 5 4 0.2 0.26 0.26 0.13 0.13
560 145 3 3 0.2 0.2 0.27 0.28 0.28 0.28
220 10 4 3 0.2 0.3 0.3 0.2 0.2
120 25 4 3 0.2 0.2 0.1
100 20 4 3 0.2 0.2 0.2
660 40 5 3 0.2 0.2 0.3 0.3 0.23 0.23
215 25 5 3 0.2 0.23 0.23 0.2 0.2
120 16 3 4 0.2 0.2 0.2
90 25 6 4 0.2 0.2 0.2
285 4 0.2 0.26 0.2 0.2 0.2
70 13 3 3 0.2 0.2 0.2
135 40 6 4 0.2 0.2 0.18 0.18
160 23 4 4 0.2 0.23 0.2 0.2
150 100 4 3 0.2 0.21 0.18 0.18 0.14
160 11 4 5 0.2 0.2 0.18
240 14 4 3 0.2 0.2 0.18 0.18 0.18
435 116 3 3 0.2 0.25 0.2 0.15 0.15 0.15
420 3 0.2 0.2 0.18 0.15 0.15 0.15
120 20 3 3 0.2 0.2 0.2
97 13 3 3 0.2 0.2 0.18
150 28 2 3 0.2 0.25 0.2 0.2
320 34 2 3 0.2 0.24 0.24 0.2 0.16 0.16
280 27 3 4 0.2 0.21 0.21 0.2 0.2 0.2
Inf_7hr Inf_8hr Inf_9hr Inf_10hr Inf_11hr Inf_12hr Sta_inf Pain_0hr Pain_1hr Pain_2hr Pain_3hr
0.2 9 8 6
0.3 10 8 8
0.2 10 8 9
0.1 9 3 1
10 8 6
0.3 10 8 8
0.2 10 7 3
0.13 10 6 3
0.28 0.28 0.28 0.28 0.2 0.2 0.2 10 8 8
0.2 10 8 4
0.1 10 6 2
0.2 10 5 3
0.2 0.2 0.2 0.2 0.2 0.2 0.2 10 8 5
0.2 10 8 6
0.2 10 6 4
0.2 10 6 4
10 6 4
0.2 10 6 6
0.18 10 3 1
0.2 10 5 3
0.14 10 5 3
0.18 10 6 6
0.18 9 8 4
0.15 0.15 0.15 0.15 10 8 7
0.15 10 7 5
0.2 10 6 4
0.18 10 5 5
0.2 10 8 5
0.16 10 8 8
0.2 10 8 7
Pain_5hr Pain_6hr Pain_7hr Pain_8hr Pain_9hr Pain_10hr Pain_11hr Pain_12hr Sed_0hr
1 0
4 4 0
8 0
1 0
1 1 0
0
1
0
5 5 5 5 5 4 5 5 1
0
0
0
4 4 4 4 4 4 4 4 0
0
0
0
3 0
0
1
0
0
1
0
5 5 5 5 5 0
3 3 3 0
0
0
0
4 3 0
4 0
Sed_1hr Sed_2hr Sed_3hr Sed_4hr Sed_5hr Sed_6hr Sed_7hr Sed_8hr Sed_9hr Sed_10hr
1 1 0 0 0
0 0 1 1 0 0
0 1 1 0 0
0 0 0 0 0
1 1 0 0 0 0
1 1
1 1 1
1 1 0 0
1 0 0 0 0 0 0 0 0
1 1 0 0
1 0
0 0
1 1 1 1 1 1 0 0 0
0 1 1 0
1 0
0 1
0 1 0 0 0
2 1
1 0 0
1 0 0
1 1 0 0
1 1
1 1 0 0
0 1 1 0 0 0 0 0 0
1 1 1 1 0 0 0
0 0
1 0
0 0 0
1 1 1 1 1 1
0 0 0 0 0
Giddiness Sedation APG-1 APG_-5
Cord-
Ph
Aver inf 
mg/kg/hr
Satis 
scor BS_SYST AB_SYS
10min_sy
s
Sed_11hr Sed_12hr TOT_KET RESCUE
TYPE 
DEL Bld loss Vomit Hallucin Dreams Nystagmus
66 1 1 100 2 2 2 1
100 1 1 200 1 2 2 2
120 2 1 350 2 2 2 1
50 1 2 200 2 2 2 1
40 1 3 250 2 2 2 2
20 1 1 100 2 2 2 1
28 1 1 50 2 2 2 2
32 1 2 150 2 2 2 2
0 0 140 1 2 300 2 2 2 2
40 1 1 200 2 2 2 2
22 1 2 200 2 2 2 2
18 1 1 150 2 2 2 1
0 0 90 1 1 100 2 2 2 2
30 1 1 100 2 2 2 2
18 1 1 150 2 2 2 2
38 1 1 200 2 2 2 2
60 1 3 350 2 2 2 2
20 1 1 100 2 2 2 2
44 1 1 250 2 2 2 1
36 1 1 200 2 2 2 2
46 1 2 150 2 2 2 1
52 1 1 200 2 2 2 2
56 1 2 200 1 2 2 2
160 1 1 150 2 2 2 2
92 1 3 400 2 2 2 2
30 1 1 250 2 2 2 2
32 1 1 100 2 2 2 2
44 1 1 100 2 2 2 2
100 1 1 175 2 2 2 2
86 1 1 100 2 2 2 2
2 2 9 10 7.249 0.21mg/kg/hr 8 110 110
1 2 9 10 7.235 0.28 7 110 116
1 2 9 10 7.195 0.32 6 136 136
2 2 9 10 7.094 0.15 9 126 130
1 2 9 10 7.236 0.09 8 116 120
2 1 9 10 7.351 0.14 4 120 124
2 1 9 10 7.184 0.25 8 130 130
2 2 9 10 7.109 0.11 8 106 100
1 2 1 9 7.052 0.18 4 116 120
1 2 9 10 7.222 0.12 9 124 124
1 2 9 10 7.237 0.15 9 120 120
1 2 9 10 7.154 0.08 6 124 120
2 1 9 10 7.121 0.09 7 126 125
1 2 9 10 7.162 0.08 6 122 126
1 2 9 10 7.234 0.09 8 120 120
1 2 9 10 7.177 0.21 8 130 130
2 1 9 10 7.258 0.16 9 110 116
2 1 9 10 7.206 0.16 7 110 110
1 2 8 10 7.21 0.19 8 118 120
2 2 6 10 7.084 0.17 8 118 120
1 2 9 10 7.187 0.18 9 120 126
2 1 9 10 7.257 0.29 8 126 130
1 2 9 10 7.288 0.15 9 126 126
1 2 9 10 7.195 0.23 8 100 96
2 1 8 10 7.214 0.18 7 112 110
1 2 9 10 7.297 0.17 8 126 126
1 2 9 10 7.348 0.21 7 110 108
2 2 9 10 7.289 0.17 7 112 110
2 1 9 10 7.189 0.2 8 128 130
2 2 9 10 7.172 0.24 8 100 98
30min_sys 60min_sys BS_DIA AB_DIA 10min_dia 30min_dia 60min_dia BS_RR AB_RR
116 110 76 80 76 76 80 22
110 116 66 70 70 70 66 70
135 136 86 90 90 90 90 22
126 120 70 76 76 78 72 20
116 120 88 86 80 80 86 18
120 120 80 80 86 82 80 18
130 128 78 82 76 70 76 17
108 110 72 70 70 72 74 19
120 110 70 80 76 76 78 21
118 120 76 72 72 80 72 15
120 120 72 80 80 80 76 18
130 128 90 92 86 86 86 21
130 130 88 86 86 84 84 20
120 120 72 76 70 72 70 16
120 124 84 84 80 80 86 18
136 136 70 70 78 78 70 16
110 110 72 68 68 70 74 15
110 100 80 76 76 82 80 18
110 110 76 70 70 76 72 18
116 120 72 70 70 78 70 17
120 124 74 70 78 74 74 16
126 126 80 80 82 80 80 15
120 120 74 70 70 80 80 16
100 100 78 80 80 80 80 16
110 110 86 90 80 86 86 17
130 130 80 82 80 76 76 16
110 118 70 72 70 76 76 14
116 110 72 72 70 76 70 18
130 130 86 86 86 80 80 15
30min_RR 60min_RR BS_HR AB_HR 10min_HR 30min_HR 60min_HR BS_FHR AB_FHR
23 22 82 84 84 80 80 126 130
23 22 76 80 76 76 80 132 134
24 22 86 85 86 84 86 132 133
19 18 79 82 82 86 82 146 142
18 16 82 82 88 89 86 136 132
20 18 76 72 76 76 80 140 132
15 14 86 80 84 88 89 126 128
17 17 86 79 78 78 82 135 139
20 20 88 86 86 90 87 124 130
15 14 92 88 90 95 92 120 116
19 19 84 88 84 84 84 129 127
20 20 92 90 93 92 90 133 136
20 20 88 88 88 86 88 138 138
17 16 82 86 86 85 80 140 128
16 19 86 86 82 90 82 139 140
19 19 88 92 88 86 80 129 132
15 16 86 90 88 88 82 130 139
20 15 90 88 88 94 88 136 138
16 18 78 82 76 76 78 134 133
16 16 89 90 88 86 86 139 143
15 14 78 82 82 80 80 131 136
15 14 72 73 79 72 72 132 138
17 16 86 80 80 89 88 132 134
16 16 82 86 80 80 79 128 130
18 15 76 80 80 80 80 126 128
17 14 88 90 90 88 86 142 143
15 15 90 90 96 90 90 130 125
15 18 88 90 88 88 86 129 130
16 14 84 84 80 80 86 135 141
14 14 88 86 88 87 88 146 143
10mn_FHR 30min_FHR 60mn_FHR
128 132 126
132 130 125
132 1140 139
139 142 147
136 133 134
136 135 139
130 126 130
128 132 130
130 128 124
130 125 124
127 130 128
132 130 129
140 141 143
142 129 129
132 129 125
130 128 122
132 129 128
129 116 120
135 128 120
128 115 136
125 132 130
120 126 126
130 128 118
128 129 120
120 119 122
128 136 140
126 129 130
122 125 129
135 138 129
138 116 140
MASTER SHEET
List of Abbreviations: 
1        age                   -   Age
2        WT                    -   Weight
3        GR -   Gravida 
4 GA   -   Gestational age 1 = term, 2= post term
5 onset      -   Onset of labour1 = spontaneous, 2= induced
6 Bolus -   Bolus dose of ketamine
7 1_stage -   duration of first stage of labour
8  2_stage -   duration of second stage
9  3_stage -   duration of third stage of labour
10 cerv.dil -   cervical dilatation at the start of study
11 inf_0.5hr - infusion rate at half an hour
12 inf_1hr -   infusion at one hour
13 inf_2hr -   infusion at second hour
14 inf_3hr -   infusion at third hour
15 inf_4hr - infusion at fourth hour
16 inf_5hr - infusion at fifth hour
17 inf_6hr - infusion at sixth hour
18 inf_7hr - infusion at seventh hour
19 inf_8hr - infusion at eight hour
20 inf_9hr - infusion at ninth hour
21 inf_10hr - infusion at tenth hour
22 inf_11hr - infusion at eleventh hour
23 inf_12hr - infusion at twelfth hour
24 sta_inf - second stage infusion
25 pain_0 - pain score at 0 hour
26 pain_1hr - pain score at 1 hour
27 pain_2hr - pain score at 2 hour
28 pain_3hr - pain score at 3 hour
29 pain_4hr - pain score at 4 hour
30 pain_5hr - pain score at 5 hour
31 pain_6hr - pain score at 6 hour
32 pain_7hr - pain score at 7 hour
33 pain_8hr - pain score at 8 hour
34 pain_9hr - pain score at 9 hour
35 pain_10hr - pain score at 10 hour
36 pain_11hr - pain score at 11 hour
37 pain_12 - pain score at 12 hour
38 sed_0hr - sedation score at 0 hour
39 sed_1hr - sedation score at 1 hour
40 sed_2hr - sedation score at 2hour
41 sed_3hr - sedation score at 3 hour
42 sed_4hr - sedation score at 4 hour
43 sed_5hr - sedation score at 5 hour
44 sed_6hr - sedation score at 6 hour
45 sed_7hr - sedation score at 7 hour
46 sed_8hr - sedation score at 8 hour
47 sed_9hr - sedation score at 9 hour
48 sed_10 - sedation score at 10 hour
49 sed_11hr - sedation score at 11 hour
50 sed_12hr - sedation score at 12 hour
51 TOT KET - total ketamine used in mgs
52 RESCUE - rescue analgesia administered 1 = no, 2 = yes
53 TYPE DEL - type of delivery 1 = normal vaginal delivery
     2 = assisted delivery
    3 = caesarean section
54 bld loss - blood loss
55 vomit - vomiting present 1 = yes, 2 = no
56 hallucin - hallucinations present 1 = yes, 2 = no
57 dreams - dreams present 1 = yes, 2 = no
58 nyst - nystagmus present 1 = yes, 2 = no
59 giddiness - giddiness present 1 = yes, 2 = no
60 sedation - sedation present1 = yes, 2 = no
61 APG_1 - apgar score at 1 minute
62 APG_5 - apgar score at 5 minutes
63 cord-ph - cord blood pH
64 aver inf - average infusion rate
65 satis score - satisfaction score
66 bs_syst -   Baseline systolic blood pressure
67 ab_syst -   Systolic blood pressure after bolus of ketamine
68 10min_sys -   systolic blood pressure 10 minutes after ketamine bolus
69 30min_sys -   systolic blood pressure 30min after ketamine bolus
70 60min_sys -   systolic blood pressure 60min after ketamine bolus
71 bs_dia -   Baseline diastolic blood pressure
72        ab_dia -   diastolic blood pressure after ketamine bolus
73 10min_dia -   diastolic blood pressure 10 minutes after ketamine bolus
74 30min_dia -   diastolic blood pressure 30 minutes after ketamine bolus
75 60min_dia -    diastolic blood pressure 60minutes after ketamine bolus
76 bs_hr -   baseline heart rate
77 ab_hr -   heart rate after ketamine bolus
78 10min_hr -   heart rate 10 minutes after ketamine bolus
79 30min_hr -   heart rate 30 minutes after ketamine bolus
80  60min_hr -   heart rate 60minutes after ketamine bolus
81 bs_fhr -   baseline fetal heart rate
82 ab_fhr -   fetal heart rate after ketamine bolus
83 10min_fhr -   fetal heart rate 10minutes after ketamine bolus
84 30min_fhr -   fetal heart rate 30minutes after ketamine bolus
85        60min_fhr -   fetal heart rate 60minutes after ketamine bolus

